Crown Bioscience Announces Four New Preclinical NASH Models In Development

Ads

You May Also Like

Delcath Sponsors Looking For A Cure Ocular Melanoma Charity Event

NEW YORK, May 22, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTHD), an interventional ...

Fennec Pharmaceuticals Receives Breakthrough Therapy Designation by FDA for PEDMARK™

RESEARCH TRIANGLE PARK, N.C., March 27, 2018 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC) ...